Making sense of asthma genes

New England Journal of Medicine

Volumn 351, Issue 17, 2004, Pages 1794-1796

  Cookson, William ^a   Moffatt, Miriam ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; GENE PRODUCT; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN D2 RECEPTOR ANTAGONIST; PROSTAGLANDIN RECEPTOR; PROTEIN ADAM33; PROTEIN DPP10; PROTEIN GPRA; PROTEIN PHF11; PROTEIN SETDB2; PROTEIN SPINK5; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR;

ASTHMA; EDITORIAL; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; HUMAN CELL; HUMAN GENOME; INTRON; PRIORITY JOURNAL; PTGDR GENE; RECEPTOR GENE; TRANSCRIPTION REGULATION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; NOTE; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ASTHMA; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 6044239102     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe048232     Document Type: Editorial

References (3)

1. Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2004;351:1752-63.
2. Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287:2013-7.
3. Lemanske RF Jr, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001;285:2594-603.